Q&A with Luigi Mari

Meet Luigi, a postdoc working on tumour immunology at St. Jude Children's Research Hospital in Memphis, USA.

Go to the profile of Dr Alison Halliday
Oct 25, 2018
0

What is your full name, job title and where do you work?

I'm Luigi Mari, a Postdoctoral Research Associate in Dept. of Immunology at St. Jude Children's Research Hospital in Memphis.

What are your main research interests?

Understanding basic mechanisms of tumor immunology to improve cancer immunotherapy.

Describe your work in a tweet

Exploring innate and adaptive immunity to boost anti-tumor immune response

What big projects are you working on right now?

I am currently focusing on basic mechanisms of antigen presentation in the context of anti-tumor immunity.

Who do you collaborate with?

Any scientist that is willing to share on behalf of scientific progress

Tell us a bit about your career so far

Graduated in Medical Biotechnology at the University of Perugia (Italy). Then obtained a PhD in tumor biology at the Academic Medical Center in Amsterdam (The Netherlands). Currently post-doc at St. Jude Children’s Research Hospital.

What are you most proud of?

I am proud of my achievements during the PhD that led to the discovering of novel mechanisms of tumor immune-evasion.

What’s your interest in the Cancer Immune Setpoint?

There is a urgent need of a platform where scientists can have an immediate overview of the different aspects that influences a response to immunotherapy

What do you hope it will achieve?

I hope it will be a reference for both scientists and clinicians in order to improve personalized therapies

What are your hopes for the future of cancer immunotherapy?

I hope that the recent progress in the sequencing field will combine to the novel immunotherapeutic drugs to provide soon a platform for decision making by clinicians.

What advice do you have for others working in the field?

I would advise to think wider instead of focusing on single molecules. Both for therapy and biomarkers. In fact, it is now clear that a good response to immunotherapy depends on several factors of the tumor microenvironment.

What do you do to wind down?

I do photography, play soccer and travel with my family.

Tell us something unusual about yourself

I would love to work in a lab in front of the sea


Are you interested in having your profile featured?

Evolving the cancer-immune setpoint can only happen with the help of our members. Keeping it up to date, improving on what’s included and adding new data that are being published all the time can only be achieved through a collective effort.

So we’re incredibly grateful to all of our members who are contributing. As a reward, you may be able to feature in a Q&A post. These profiles are highlighted to all members of our community (there’s over 1,000 of us now!), so it’s a really great way to raise your profile among your peers!

So please don’t be shy - go to the website (on a computer rather than mobile) and add to or comment on the interactive framework. All contributions are welcome, no matter how big or small!

Please see our ‘how to’ post if you need a quick reminder about what you need to do.

Go to the profile of Dr Alison Halliday

Dr Alison Halliday

Community Manager, Nature Research

Molecular Biologist turned freelance science communicator, with 10 year's experience at Cancer Research UK.

No comments yet.